CoChat
Sign Up
Cited by 325

The DOI matches its Crossref record.

The Discovery of Ezetimibe: A View from Outside the Receptor

Clader, John W.·2004·Journal of Medicinal Chemistry
DOI 10.1021/jm030283g
Open this paper in CoChat — free account

Abstract

The term “rationale drug design ” has been used for more than 30 years to describe a marriage of experiment and technology intended to promote a more directed approach toward drug discovery, often focusing on

Overview

Integrity signals

Registry

Crossref · 10.1021/jm030283g

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 36

  1. For, 1999, see the following. (a) Parrill
  2. Cushman D. W., 1977, Biochemistry, 16, 5491, 10.1021/bi00644a014 · DOI
  3. Strader C. D, 1996, J. Med. Chem., 39, 1, 10.1021/jm961181b · DOI
  4. Earl J., 2003, Nat. Rev. Drug Discovery, 2, 98, 10.1038/nrd1015 · DOI
  5. Darkes M. J. M., 2003, Am. J. Cardiovasc. Drugs, 3, 76
  6. Bruckert E, 2003, Expert Opin. Invest. Drugs, 12, 335, 10.1517/13543784.12.3.325 · DOI
  7. Gylling H., 2002, Curr. Opin. Invest. Drugs, 3, 1323
  8. Gupta E. K., 2002, Heart Dis., 4, 409
  9. Bays H., 2002, Expert Opin. Invest. Drugs, 11, 1604, 10.1517/13543784.11.11.1587 · DOI
  10. Meng C. Q., 2002, Curr. Opin. Invest. Drugs, 3, 432
  11. Sliskovic D. R., 2002, Prog. Med. Chem., 3, 171
  12. Schnitzer-Polokoff R., 1991, Comp. Biochem. Physiol., 99, 670, 10.1016/0300-9629(91)90147-5 · DOI
  13. Clader J. W., 1995, J. Med. Chem., 38, 1607, 10.1021/jm00010a004 · DOI
  14. Vaccaro W., 1996, J. Med. Chem., 39, 1719, 10.1021/jm950833d · DOI
  15. Sliskovic D. R., 1991, Trends Pharmacol. Sci., 323, 1298
  16. Burnett D. A., 1994, J. Med. Chem., 37, 1736, 10.1021/jm00038a001 · DOI
  17. Clader J. W., 1996, J. Med. Chem., 39, 3693, 10.1021/jm960405n · DOI
  18. Salisbury B. G., 1995, Atherosclerosis, 115, 63, 10.1016/0021-9150(94)05499-9 · DOI
  19. Dugar S., 1995, J. Med. Chem., 38, 4877, 10.1021/jm00025a002 · DOI
  20. Dugar S., 2000, S. R.
  21. Van Heek M., 1997, J. Pharmacol. Exp. Ther., 283, 163
  22. 1996, Bioorg. Med. Chem. Lett., 6, 1950
  23. Rosenblum S. B., 1998, J. Med. Chem., 41, 980, 10.1021/jm970701f · DOI
  24. Homann M. J., 2000, Stereoselective microbial reduction for the preparation of 1-(4-fluorophenyl)-3(R)-[3(S)-hydroxy-3-(4-fluorophenyl)propyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone. U.S. Patent 6,133,001
  25. Thiruvengadam T. K., 2000, Process for the synthesis of azetidinones and intermediates for use as hypocholesterolemics. Patent WO0034240
  26. Wu G., 1999, J. Org. Chem., 64, 3718
  27. Wu G.-Z., 1999, A process for the enantioselective preparation of azetidinones using 3-hydroxy gamma-lactone. U.S. Patent 5,886,171
  28. Shankar B. B., 1999, Process for preparing 1-(4-fluorophenyl)-3(R)-(3(S)-hydroxy-3-([phenyl or 4-fluorophenyl])-propyl)-4(S)-(4-hydroxyphenyl)-2-azetidinone. U.S. Patent 5,856,473
  29. Wu G.-Z., 1997, 3-Hydroxy gamma-lactone based enantioselective synthesis of azetidinones. Patent WO9745406
  30. Shankar B. B., 1996, Tetrahedron Lett., 37, 4098, 10.1016/0040-4039(96)00764-2 · DOI
  31. Burnett D. A, 1994, Tetrahedon Lett., 35, 7342, 10.1016/0040-4039(94)85308-8 · DOI
  32. Davis H. R., 2001, Metab., Clin. Exp., 50, 1241, 10.1053/meta.2001.26737 · DOI · Paper page
  33. Dujovne C. A., 2002, Am. J. Cardiol., 90, 1097, 10.1016/S0002-9149(02)02798-4 · DOI
  34. Davidson M. H., 2002, J. Am. Coll. Cardiol., 40, 2134, 10.1016/S0735-1097(02)02610-4 · DOI
  35. Gagne C., 2002, Am. J. Cardiol., 90, 1091, 10.1016/S0002-9149(02)02774-1 · DOI
  36. Ballantyne C. M., 2003, Circulation, 107, 2415, 10.1161/01.CIR.0000068312.21969.C8 · DOI

Cited by

Sorted by citations

Metadata

Authors
Clader, J. W.
Affiliations
Cardiovascular and CNS Medicinal Chemistry Department, Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033-0539
Venue
Journal of Medicinal Chemistry
Publisher
American Chemical Society (ACS)
Published
2003-12-09
Volume
47
Issue
1
Pages
1-9
ISSN
  • 0022-2623
  • 1520-4804
DOI
10.1021/jm030283g
Cited by
325
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review